Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Goodwill & Intangibles (2015 - 2026)

Mesoblast (MESO) posted Goodwill & Intangibles of $568.8 million for Q4 2025, down 0.53% sequentially from $571.8 million in Q2 2025, and down 1.06% YoY from $574.9 million in Q4 2024.

Analysis

Mesoblast (MESO) Goodwill & Intangibles (2015 - 2026) Analysis & Trends

Mesoblast has reported Goodwill & Intangibles for 11 years, with the latest figure at $568.8 million in Q4 2025.

  • Quarterly Goodwill & Intangibles fell 1.06% year-over-year to $568.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $568.8 million (down 1.06% YoY) and the FY2025 annual result came in at $571.8 million, down 0.68% from the prior year.
  • Goodwill & Intangibles retreated to $568.8 million in Q4 2025 per MESO's latest filing, from $571.8 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $698.9 million in Q2 2021 and troughed at $568.8 million in Q4 2025.
  • A 5-year average of $593.1 million and a median of $578.3 million in 2022 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2021 and 2023: Goodwill & Intangibles grew 20.18% in 2021, then fell 16.9% in 2023.
  • Over 5 years, Goodwill & Intangibles stood at $579.8 million in 2021, then fell by 0.33% to $577.9 million in 2022, then slipped by 0.23% to $576.6 million in 2023, then decreased by 0.29% to $574.9 million in 2024, then fell by 1.06% to $568.8 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $568.8 million, $571.8 million, and $574.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 566.37 Mn
Dec 31, 2025 568.80 Mn
Jun 30, 2025 571.83 Mn
Dec 31, 2024 574.88 Mn
Jun 30, 2024 575.74 Mn
Dec 31, 2023 576.56 Mn
Jun 30, 2023 577.18 Mn
Mar 31, 2023 577.53 Mn
Dec 31, 2022 577.90 Mn
Sep 30, 2022 578.28 Mn
Jun 30, 2022 578.65 Mn
Mar 31, 2022 578.95 Mn
Dec 31, 2021 579.84 Mn
Sep 30, 2021 580.18 Mn
Jun 30, 2021 580.55 Mn
Mar 31, 2021 580.94 Mn
Dec 31, 2020 581.33 Mn
Sep 30, 2020 581.22 Mn
Jun 30, 2020 581.60 Mn
Mar 31, 2020 581.94 Mn